Why the study?
How should patients with silent cardiac ischemia be managed to prevent future events?
How should patients with silent cardiac ischemia be managed to prevent future events?
This review highlights the clinical dilemma of treating asymptomatic patients with documented cardiac ischemia and the need to justify interventions by preventing future events.
Authors
No takes yet. Share an insight, caveat, or question.
Silent ischemia management in asymptomatic patients warrants caution; ACIP review leaves open optimal preventive strategies.
C. Richard Conti (2002) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: